Skip to content

Drug interactions

Rabeprazole + Rucaparib

Severity: Minor

Rabeprazole and Rucaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib inhibits CYP2C19 and CYP3A4 weakly to moderately, and these are minor pathways for rabeprazole. Any increase in rabeprazole exposure is likely small and of little consequence given its wide safety margin.

What this interaction means in plain words

Rabeprazole and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Rabeprazole belongs to Gastrointestinal Tract; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Rucaparib inhibits CYP2C19 and CYP3A4, minor routes of rabeprazole metabolism.

What to do

No routine adjustment is needed; monitor for PPI-related adverse effects during long-term co-use.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rabeprazole and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rabeprazole with Rucaparib?

MediHelp rates the interaction as minor. Rabeprazole and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib inhibits CYP2C19 and CYP3A4 weakly to moderately, and these are minor pathways for rabeprazole. Any increase in rabeprazole exposure is likely small and of little consequence given its wide safety margin.

How serious is the interaction between Rabeprazole and Rucaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; monitor for PPI-related adverse effects during long-term co-use.

What other medicines interact with Rabeprazole?

MediHelp also lists interactions of Rabeprazole with, for example, Rilpivirine, Acalabrutinib, Atazanavir. The full list is on the Rabeprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in